Eterna Therapeutics
ERNA
#10302
Rank
โ‚น0.69 B
Marketcap
โ‚น25.81
Share price
-1.68%
Change (1 day)
-92.97%
Change (1 year)

EPS for Eterna Therapeutics (ERNA)

EPS in 2025 (TTM): -โ‚น6,436

According to Eterna Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น7,064. In 2022 the company made an earnings per share (EPS) of -โ‚น11,589 an increase over its 2021 EPS that were of -โ‚น76,566.

EPS history for Eterna Therapeutics from 2021 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น6,436
2022-โ‚น11,589-84.86%
2021-โ‚น76,566

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
โ‚น190.17-102.69%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-โ‚น60.78-99.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
-โ‚น186.02-97.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-โ‚น11.05-99.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
N/AN/A๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
โ‚น114.19-101.62%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
โ‚น47.89-100.68%๐Ÿ‡บ๐Ÿ‡ธ USA